as 11-15-2024 4:00pm EST
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
Founded: | 2004 | Country: | Israel |
Employees: | N/A | City: | N/A |
Market Cap: | 5.1M | IPO Year: | 2015 |
Target Price: | N/A | AVG Volume (30 days): | 29.4K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.00 | EPS Growth: | N/A |
52 Week Low/High: | $0.76 - $3.62 | Next Earning Date: | 11-25-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
CHEK Breaking Stock News: Dive into CHEK Ticker-Specific Updates for Smart Investing
GuruFocus.com
5 months ago
Energy Global
5 months ago
USA TODAY
5 months ago
Business Wire
5 months ago
Business Wire
5 months ago
GlobeNewswire
5 months ago
Reuters
5 months ago
GlobeNewswire
5 months ago
The information presented on this page, "CHEK Check-Cap Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.